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Development of the ACTIVE framework to describe 
stakeholder involvement in systematic reviews 
 
ABSTRACT 
Objectives 
Involvement of patients, health professionals, and the wider public (‘stakeholders’) is seen to be 
beneficial to the quality, relevance and impact of research and may enhance the usefulness and 
uptake of systematic reviews. However, there is a lack of evidence and resources to guide 
researchers in how to actively involve stakeholders in systematic reviews. In this paper we report 
the development of the ACTIVE framework to describe how stakeholders are involved in 
systematic reviews.   
Methods 
We developed a framework using methods previously described in the development of conceptual 
frameworks relating to other areas of public involvement, including: literature searching, data 
extraction, analysis, and categorisation. A draft ACTIVE framework was developed and then 
refined after presentation at a conference workshop, before being applied to a series of example 
systematic reviews.  Data extracted from 32 systematic reviews, identified in a systematic scoping 
review, were categorised against pre-defined constructs, including: who was involved, how 
stakeholder were recruited, the mode of involvement, at what stage there was involvement and 
the level of control or influence.   
Results  
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The final ACTIVE framework described whether patients, carers and/or families, and/or other 
stakeholders (including health professionals, health decision makers and funders) were involved. 
We defined: recruitment as either open or closed; the approach to involvement as either one-
time, continuous or combined; and the method of involvement as either direct or indirect. The 
stage of involvement in reviews was defined using the Cochrane Ecosystem stages of a review. 
The level of control or influence was defined according to the roles and activities of stakeholders 
in the review process, and described as the ACTIVE continuum of involvement.  
Conclusions 
The ACTIVE framework provides a structure with which to describe key components of 
stakeholder involvement within a systematic review, and we have used this  to summarise how 
stakeholders have been involved in a subset of varied systematic reviews. The ACTIVE continuum 
of involvement provides a new model that uses tasks and roles to detail the level of stakeholder 
involvement. This work has contributed to the development of learning resources aimed at 
supporting systematic review authors and editors to involve stakeholders in their systematic 
reviews.    This framework may support the decision-making of systematic review authors in 
planning how to involve stakeholders in future reviews. 
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INTRODUCTION 
Systematic reviews are an essential part of the research cycle, identifying and bringing together, in 
an explicit and transparent way, the research evidence that addresses a particular topic or health 
care question. They play a vital role in informing what is known about a topic, and what is not 
known, to support health care and policy decisions. However, there are several barriers to the 
implementation of evidence from systematic reviews into practice, including lack of access, 
familiarity and use, and lack of perceived usefulness by those who are expected to use them.1   
Involving stakeholders in systematic reviews has been proposed as a way to address these 
barriers, and to enhance the actual and perceived usefulness of synthesised research evidence. 
Existing work has focused, largely, on the active involvement of patients and the wider public in 
research, finding this  to be beneficial to the quality, relevance and impact of research,2-5 and 
likely to reduce research waste.6 Patient and public involvement (PPI) is mandatory in countries 
such as the United Kingdom for funded research activities, including systematic reviews.7 
INVOLVE,  a national advisory body funded by the National Institute for Health Research (NIHR) in 
England, provides guidance on research co-production and briefing notes on the principles for 
public involvement in research, including in systematic reviews,8, 9 with good practice including 
careful planning, clear communication, defining roles and responsibilities, provision of training 
and appropriate financial reimbursement.7-10  Effective relationships between researchers and 
involved patients / members of the public  are core, with behaviours such as respect, trust, 
confidentiality, clarity and clear communication central to successful involvement.8, 11     
Despite the establishment of good practice principles, there is a growing awareness of the need 
for more practical resources to support the involvement of patients, the wider public and other 
stakeholders in research.8  An increasing number of guidance documents and frameworks is 
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available,7, 10 such as the Public Involvement Impact Assessment Framework,12 which is designed 
to help researchers assess the impact of public involvement, while GRIPP213 provides guidance for 
the reporting of patient and public involvement. At the same time, there remains insufficient 
knowledge about methods or approaches of how to (best) involve stakeholders across the 
different stages in the production of a systematic review.14-16  
This study seeks to contribute to closing this gap by developing a framework to describe methods 
and approaches to stakeholder involvement used in systematic reviews, the ‘ACTIVE framework’. 
The work was conducted as part of the ACTIVE project (Authors and Consumers Together 
Impacting on eVidencE), which developed an online learning resource to support systematic 
review authors in involving stakeholders in their systematic reviews.     
METHODS 
Definition of key terms 
Internationally there is considerable inconsistency in terminology and definitions of stakeholder 
involvement. As noted, it is often referred to as ‘patient and public involvement’ (PPI). We here 
define a stakeholder as any person who uses research knowledge but whose primary role is not 
directly in research.17 Stakeholders thus include: patients, carers and family members, or people 
interested in remaining healthy who are seeking information about a health condition or 
treatment for personal use; members of organisations that represent people who use services; 
people with a professional role in health and social care; and policymakers and managers.   
Cochrane, a global collaboration which produces systematic reviews, uses the term ‘consumer’, to 
mean patients and the public,15 and we use this term where patients or the public specifically 
describe themselves as Cochrane ‘consumers’.   
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We define involvement in a systematic review as any role or contribution of stakeholders toward 
the development of a review protocol, completion of any of the stages of a systematic review, or 
dissemination of the findings of a review, while a systematic review as defined as a research 
process in which literature relevant to a stated question was identified and brought together 
(synthesised) using explicit methods,18 including reporting of  inclusion/exclusion criteria, search 
methods and details of included studies.   
Literature searching, data extraction and analysis 
The ACTIVE framework was developed using methods similar to those described for the 
development of conceptual frameworks in other areas of public involvement.19, 20 We first 
undertook a scoping review, using an iterative team approach as described by Arksey and 
O’Malley,21 to create a broad map of evidence relating to stakeholder involvement in systematic 
reviews. The scoping review, which has been fully reported elsewhere,16, 22 identified 291 papers 
which described stakeholder involvement in systematic reviews. We developed a data extraction 
form, which sought to capture and summarise the key features considered important to 
describing how stakeholders were involved; the components of the extraction form were 
discussed and agreed between all team members prior to use. One reviewer (AP) then extracted 
the data, capturing information on the aim/s of the systematic review, a narrative description of 
the involvement of stakeholders, details of who was recruited, how they were recruited, the mode 
of engagement (e.g. face-to-face meeting, electronic surveys etc), and any formal research 
methods used (e.g. participatory action research, nominal group technique, Delphi approach). 
Data were tabulated into an Excel spreadsheet. 
Categorising data and development of the ACTIVE framework 
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The author team explored and mapped the tabulated data to pre-defined constructs of interest, 
by means of a full-day, face-to-face meeting (AP, PC, RM, CS), using whiteboards to generate and 
record ideas, which informed the development of an initial proposal for the structure and content 
of the ACTIVE framework. The proposal was shared with the wider research team for feedback 
and refinement through email and teleconferences, until consensus was achieved on key 
constructs of interest which should be brought together within a framework. During this process, 
background literature relevant to each construct of interest, including existing models and 
systems, was explored in order to justify and agree definitions and subcategories for each 
construct. Five key constructs, each comprising a number of categories, were defined: (i) Who was 
involved?, (ii) How were stakeholders recruited?, (iii) What was the mode of involvement 
(approach and methods)?, (iv) At what stage in the review process did involvement occur?, and (v) 
What was the level of involvement (level of control or influence over the review process)?.   
From the 291 papers identified in the scoping review, a sub-set of 32 systematic reviews 
(described in 30 papers) that were judged to provide the most comprehensive description of 
stakeholder involvement were identified (Online Supplement 1). Data extracted from these 
reviews were categorised according to each of the five constructs, to test and inform the structure 
of the framework. One reviewer (AP) categorised data relevant to the first four of the five 
constructs, consulting a second reviewer (CS or RM) where there was uncertainty.  As the research 
team considered that categorising data from the systematic reviews according to the definitions 
for the fifth construct (level of control or influence over the review process) required a greater 
degree of interpretation of data this was carried out by two reviewers (AP, CS) independently, 
with any disagreements resolved through discussion, involving a third reviewer (RM) where 
necessary. Following data categorisation, two reviewers (AP, RM) reviewed the categorised data 
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and structured the five constructs within a draft ACTIVE framework, which was then shared and 
agreed with the full author team.  
The draft ACTIVE framework was presented at a workshop held at the annual UK Cochrane 
symposium (see Online Supplement 2). Workshop participants comprised approximately 30 
Cochrane symposium delegates who chose to attend this parallel worshop, and included a broad 
mix of systematic review authors, editors and consumers with an interest in this topic (some with 
and some without any experience of stakeholder involvement). During the workshop, participants 
considered the descriptions of involvement from the 32 systematic reviews and how these were 
categorised within the framework categorisation, working in groups to provide  comments and 
feedback (see Online Supplement 2). Workshop feedback informed further refinement and a final 
ACTIVE framework was agreed by all members of the author team.  
Stakeholder involvement  
One consumer (HG) and two consumer representatives (RM, CS) were active members of the 
ACTIVE project and author team, from being co-applicants on the funding application, the conduct 
of the evidence synthesis, the planning of the workshop and the drafting of this manuscript (see 
Online Supplement 3). 
RESULTS 
Figure 1 illustrates the ACTIVE framework and Table 1 summarises stakeholder involvement 
reported in the 32 systematic reviews using the framework. In the following we report on the key 
findings which contributed to the categorisation and structure of  the five constructs within the 
ACTIVE framework. 
Who was involved? 
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The 32 systematic reviews reported to have involved a range of stakeholders, including people 
with a health care condition and/or their family/carer, health professionals or other professional 
stakeholders. The language used to describe stakeholders was inconsistent, and clear descriptions 
of who precisely was involved were often lacking.  
The review by Concannon et al. developed the 7Ps framework to describe the key groups of 
people who may be stakeholders involved in research.23 These are: patients and the public; 
providers; purchasers; payers;  policymakers; product makers; and principal investigators.  
However, in seeking to apply this framework to the systematic reviews included in our study we 
found that information provided was generally insufficient to allow for clear-cut categorisation of 
stakeholders into one of the 7 groups. Indeed, it was often impossible to distinguish between 
different professional groups involved. Building on the evidence review, aiming to provide a 
framework that supports systematic review authors in involving stakeholders, rather than 
attempting to categorise multiple groups of stakeholders, often with limited information, the 
ACTIVE frameword uses a simplified categorisation, distinguishing patients, carers and/or family 
members, and/or any other identified stakeholder (Figure 1). The majority of reviews (14/32) 
included in this study involved all three groups (Table 1). 
How were stakeholders recruited? 
We identified two broad categories of stakeholder recruitment, ‘open’ and ‘closed’ recruitment. 
‘Open’ recruitment refers to providing opportunities for involvement through advertisement to 
the general population, allowing anyone to volunteer to get involved. Open recruitment may 
result in ‘fixed’ membership, where, once group members had volunteered, the membership 
remains the same, or in ‘flexible’ membership, where different people attend different events or 
contribute to different activities. Conversely, ‘closed’ (or ‘targeted’) recruitment strategies focus 
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on inviting only specific people to participate. Closed strategies include invitation of known 
individuals or recognised experts, recruitment from membership of an existing group, or 
purposive sampling to achieve representation of people with key pre-determined characteristics, 
experience or expertise.   
What was the mode of involvement? 
Ways of involving stakeholders in a systematic review varied. We identified two general 
categories, which we described in our framework as ‘approach’ to and ‘method’ of involvement.   
Approach to involvement refers to the general way in which stakeholders were involved 
throughout the stages of a systematic review, and this is also related to the role that the 
stakeholders had in the review process (see also ‘stage of involvement’ below). We identified two 
distinct approaches to involvement, one-time (i.e. one-off) and continuous involvement.2, 24 One-
time involvement describes an approach that involves stakeholders at a specific stage of a review, 
for example when developing the question for the review, or writing lay-summaries of a 
completed review. One-time involvement can occur at just one stage or at multiple stages in the 
review process. Continuous involvement refers to the involvement of the same stakeholders 
throughout the entire review process. Continuous involvement approaches fell into three broad 
types: partnership, multiple-time closed event, and hands-on approaches (see Box A for 
definitions of these types), although differences between types were not clear-cut, with some 
areas of overlap between them. Stakeholders who had an oversight role (for example, on a project 
advisory group) would often also have input at one or more specific stages of the review (for 
example, getting involved to assist with study selection). Where this occurred, but only one group 
of stakeholders was involved during the review process, we still categorised this as continuous 
involvement. Combined approaches describe instances of the involvement of two (or more) 
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distinct groups of stakeholders, with some having continuous involvement and an oversight role, 
while others had input at one or more specific stages of the review.   
The systematic reviews included in our study broadly described two distinct methods of 
involvement, those using direct interaction between stakeholders and the review team, through 
face-to-face or virtual (e.g. Skype or teleconference) meetings (direct method), and those where 
there was no direct (indirect) interaction between stakeholders (indirect method) (see Figure 1). 
In the indirect method, involvement occurred through participation in an electronic Delphi 
method to reach group consensus on a particular issue relating to the review. Some of systematic 
reviews combined involvement in an electronic Delphi method with a face-to-face consensus 
meeting. Where both direct and indirect methods were used in the same systematic review we 
categorised this as ‘direct’, since there was direct interaction in addition to other approaches. 
At what stage in the review process did involvement occur? 
As indicated above, involvement can occur at any stage in a systematic review. To help 
systematically categorise the stage(s) of the systematic review process where there was 
involvement, we used the stages described within the ‘Cochrane Ecosystem’ 25, which includes 
eleven sequential stages, from developing the question, planning the methods and protocol; 
develop and run the searches; collect and analyse data; to interpret findings and publish the 
review. Based on our review, we added a twelfth stage, which we refer to as knowledge 
translation and impact (Figure 1).    
We noted earlier that the stage of involvement is closely linked to the approach to involvement, 
which we have described as one-time, continuous or combined. Categorising stages of 
involvement across the 32 systematic reviews, we identified a number of reviews (8/32) in which 
there was involvement at the initial stages (stage 1-3: framing the question and planning the 
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review) and at the final stages (stage 10-12: interpretation, publication and dissemination of 
findings), but no involvement in the middle stages (stage 4-9: conducting the review). As this was 
the most common pattern of involvement of stakeholders across the different stages of a review 
which we observed, we named this the ‘top and tail’ approach, and highlighted where this 
approach was used (see Table 1). 
What was the level of involvement?  
Our review found that the extent to which stakeholders were involved, and their degree of control 
over decisions being made in the systematic review process, could vary considerably. Terminology 
to describe the level of involvement or degree of control of stakeholders was inconsistent, 
however. Building on the review evidence and workshop feedback, and further informed by 
existing models that describe levels of involvement, such as INVOLVE 9, which distinguishes 
‘involvement’, ‘participation’ and ‘engagement’; Popay26 who defined five levels of involvement; 
and models that describe involvement, or participation, as a continuum (see Online Supplement 4 
for examples of models of involvement or participation), we defined a classification that is based 
specifically on the tasks and roles of people involved in systematic reviews. Through an iterative 
process of feedback and refinement this lead to the ACTIVE continuum of involvement, which 
ranges from ‘leading’, ‘controlling’ and ‘influencing’ to ‘contributing’ and ‘receiving’ (Figure 2). 
None of the involvement within the 32 systematic reviews was considered to be ‘leading’; 
however this was considered to be an important category, with workshop feedback highlighting 
that it was deemed essential that this was a distinct category, separate from the category of 
‘control’.  Most commonly, involvement in the 32 systematic reviews was at the level of 
‘influencing’, with stakeholders ‘controlling’ decisions in only 3 of the reviews.   
DISCUSSION  
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This paper presents the ACTIVE framework, which was developed iteratively based on synthesised 
evidence, providing  a structure to guide authors on how to involve stakeholders in the systematic 
review process in a transparent way, using clearly defined terminology. It proposes the ACTIVE 
continuum of involvement, which categorises level of involvement based on the tasks and roles of 
stakeholders. We have applied the ACTIVE framework on a subset of systematic reviews which 
describe stakeholder involvement in systematic reviews, highlighting that there is no set formula 
or single method of involving people in a systematic review.  
In doing so, the framework goes a step further than the INVOLVE national guidance on research 
co-production in the UK8 described earlier, which lacks detail on practical issues on how to involve 
stakeholders in specific types of research. The ACTIVE online learning resources27 has been 
structured around the ACTIVE framework, with the use of icons to facilitate clear, accessible 
categorisation of stakeholder involvement within different systematic reviews (see icons 
developed for the online learning resource in Online Supplement 5).  These resources will be 
useful for researchers planning stakeholder involvement in future systematic reviews and, as such, 
they have the potential to enhance reporting and consistency of terminology in future reviews. 
The ACTIVE framework also usefully adds to existing generic guidance on reporting of stakeholder 
involvement in research such as GRIPP213, which has not been tested for use with systematic 
reviews and does not provide guidance on reporting of how stakeholders are specifically involved 
within the systematic review process.  Initial feedback on the use of icons within the framework 
highlighted that these were considered to provide clarity to the categorisation, make the 
information more easily accessible, providing an understanding of involvement in different 
reviews ‘at a glance’. 
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While the ACTIVE framework has not been developed as a decision-making tool, and is unlikely to 
be comprehensive of all decisions required, we believe that consideration of the constructs within 
the framework will support the planning stages of involving stakeholders in a new systematic 
review. This study highlights that there is no set formula or single method of involving people in a 
systematic review.   
Factors which will influence decisions around the methods of involvement in a specific systematic 
review are likely to include the review topic and the stakeholders who may be affected by the 
results of the review; the aims of involving stakeholders, which may be highly specific (e.g. to 
decide on the outcomes of interest to a review) or may be more generic (e.g. to ensure the review 
is relevant); the available resources, including the time and funding available to carry out the 
review and involve key stakeholders in the process; the expertise and experience of researchers; 
along with the conditions ensuring meaningful involvement, such as key principles for good 
practice in stakeholder involvement (described earlier),  the wider research environment, and 
stakeholder and researcher expectations, support and a sense of feeling valued.20, 28 In addition, 
decisions may be influenced by a desire for review findings to be generalisable to a local, national 
or international population. Thus, there is clearly a  complex interdependency between the 
constructs within the ACTIVE framework and external factors which will impact on  decisions 
about stakeholder involvement in future reviews.  
Strengths and limitations 
To our knowledge, this is the only framework specifically describing stakeholder involvement in a 
systematic review. As noted it was developed using a comprehensive scoping review and with 
stakeholder involvement. The 32 systematic reviews used to test and refine the framework 
include a wide range of approaches (including qualitative and quantitative reviews) and focused 
14 
 
on a different health topics,22 which will enhance the applicability of the framework to a range of 
review types and topics.   
There were a number of limitations with the scoping review on which this framework 
development was based; these have been described in detail elsewhere.22 The framework was 
tested and refined based on data extracted from published systematic reviews; we did not contact 
systematic review authors  for further information or clarification relating to their involvement of 
stakeholders. This may have limited our understanding and interpretation of the methods of 
involving stakeholders and the activities in which stakeholders were involved. Furthermore, we 
used the Cochrane Ecosystem25  to categorise the stages of a systematic review; however these 
stages have primarily been developed to describe the process of synthesising quantitative 
evidence relating to effectiveness, and key stages in the methods of other types of reviews (e.g. 
realist reviews) may not have been appropriately categorised.   
There are also limitations to our approach to dichotomising data under the construct of “who was 
involved”.  This was a pragmatic decision based on the information that was most commonly 
available in the systematic reviews included in this study. We recommend that this is reviewed, 
and potentially expanded, when reporting of types of stakeholders has improved.  
Within this study we specifically extracted data from a subset of reviews where the methods of 
involvement were well described, but as the reporting of involvement in reviews is generally poor, 
it is unlikely that this subset will be comprehensive of all approaches to involvement within 
reviews. For example, our lack of examples where stakeholders were ‘leading’ does not provide 
evidence of absence; indeed there are examples of systematic reviews where stakeholders did 
play a key role, such as a recent Cochrane review, which was initiated and co-led by consumers,e.g. 
29 but the role and involvement of consumers in the review text was not reported clearly.  
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During the development of the ACTIVE continuum of involvement we explored the ‘tasks’ 
described in included systematic reviews by considering the narrative description of the 
involvement of stakeholders, details of what happened and any formal research methods used. It 
was a post-hoc decision to explore tasks in this way, and we did not use a pre-planned approach 
to extract and categorise details of these tasks. Future work should consider tasks as a distinct 
construct at the outset. The ACTIVE continuum of involvement has not been tested beyond these 
examples, and further testing and (possibly) refinement is required. 
As noted, we presented a draft framework at a workshop in the UK and collected informal 
feedback (see Online Supplement 2). Furthermore, stakeholder involvement in the development 
of this framework has been limited to the members of the author team and the select group of 
conference delegates who chose to attend the workshop. The ACTIVE framework would be 
strengthened by more rigourous testing and peer review, with input from a wider group of 
international stakeholders.  
Practice and policy relating to stakeholder involvement in research is rapidly evolving. In addition 
to the examples described earlier, other examples include the recent launch of an international 
network for public involvement and engagement in health and social care (#globalPPInetwork), 
and the requirement by the British Medical Journal of a patient and public involvement statement 
in all research articles.30 Our work adds to this growing body of resources, providing focussed, 
practical, information relating to how to involve stakeholders in systematic reviews. 
CONCLUSION 
This paper presents the ACTIVE framework for describing the range of methods and approaches 
for involving stakeholders in systematic reviews. This work has contributed to the development of 
learning resources to support researchers to involve stakeholders in their systematic reviews. The 
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ACTIVE continuum of involvement defines different levels of stakeholder involvement, 
contributing to the transparent use and consistent reporting of involvement in the review process. 
The ACTIVE framework has the potential to support systematic review authors in their planning of 
how to involve stakeholders at the different stages of the review process, so improving 
stakeholder involvement overall and, in turn, enhancing the quality, relevance, and impact of 
systematic reviews.   
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Framework Constructs Categories 
Who was involved? Patients, carers and / or their families 
Patients, carers and / or their families + other stakeholders 
Other stakeholders only 
How were 
stakeholders 
recruited? 
Open  Fixed 
Flexible 
Closed Invitation 
Existing group 
Purposive sampling 
What was the mode of 
involvement? 
Approach? One-time 
Continuous 
Combined (i.e. both one-time and continuous) 
Methods? Direct interaction 
No direct interaction 
At what stage in the review process 
did involvement occur? 
 
 
 
 
 
 
 
 
 
 
 
 
What was the level of involvement  
(at each stage)? 
 
Leading 
Controlling 
Influencing 
Contributing 
Receiving 
FIGURE 1:  The ACTIVE framework of involvement in a systematic review  
  
1 
Develop 
question 
2 
Plan 
methods 
3 
Write & publish 
protocol 
4 
Develop 
search 5 
Run 
search 
6 
Select 
studies 
7 
Collect 
data 
8 
Assess risk 
of bias 9 
Analyze 
data 
10 
Interpret 
findings 
11 
Write & 
publish 
i  
12 
Knowledge 
translation & 
impact 
ACTIVE 
stages of a 
systematic 
review 
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People are: Tasks: 
LEADING: Initiating the review; lead responsibility 
for carrying out and completion of review. 
Tasks will include authorship of a review, and 
may include any activities associated with review 
completion, including key decisions relating to 
the methods and execution of the review. 
CONTROLLING: Working in partnership with 
researchers, with varying degrees of control or 
influence over the review process. Making decisions 
and/or controlling one or more aspects of the 
review process, in collaboration with or under the 
guidance of the review authors.  
Tasks may include defining outcomes of interest, 
inclusion criteria, key messages arising from 
review findings and writing a plain language 
summary.   
In completing tasks people have control over 
final decisions, such as application of inclusion 
criteria, categorisation of interventions, or 
recommendations for clinical practice. 
INFLUENCING: Stating, commenting, advising, 
ranking, voting, prioritising, reaching consensus. 
Providing data or information which should directly 
influence the review process, but without direct 
control over decisions or aspects of the review 
process.  
Tasks may include assisting with review tasks, 
such as hand-searching, screening, data 
extraction and assessment of risk of bias, 
possibly in a co-reviewer role.    
Tasks may include peer review, such as 
commenting on a protocol, systematic review or 
plain language summary. 
CONTRIBUTING: Providing views, thoughts, 
feedback, opinions or experiences. Providing data or 
information which may indirectly influence the 
review process. People may be participants in a 
research study (e.g. focus groups or interviews).  
Tasks may include sharing views or opinions, for 
example within a focus group of interview. May 
include ranking, voting or prioritising as 
participants in a research study (e.g. Delphi 
study).   
RECEIVING: Receiving information about the 
systematic review, or results of the review. 
Tasks may include attending events, or reading or 
listening to information about the review.  While 
the results of a review may be discussed, these 
discussions do not influence the review process 
in any way. 
 
FIGURE 2:  ACTIVE continuum of involvement, describing the level of involvement, or control, 
that stakeholders have in a systematic review 
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Partnership approach: In this approach a small group of stakeholders were on a steering 
committee or management group and contributed on a regular basis, attending meetings or by 
teleconference or email.  This same group of stakeholders may also have input at one or more 
specific stages of the review (e.g. writing a lay summary), but the primary role of this closed 
group of stakeholders was one of oversight or management.   
Multiple-time closed event approach: In this approach the same small (fixed) group of 
stakeholders had two or three face-to-face meetings, each at specific stages within the review 
process, and focussed on the completion of a particular task or role (e.g. agreeing scope of the 
review).  In addition this same small group of stakeholders remain in touch about the progress 
of the review, providing some degree of oversight or management throughout the review 
process, which often occurs through email, phone and newsletter.   
Hands-on approach:  In this approach researchers and stakeholders worked together to plan 
and conduct the research.  The key distinguishing features of this approach, when used within 
our example systematic reviews, appears to be that the stakeholders involved contribute to 
relatively frequent review meetings, although methods of recruitment and format of 
involvement can vary considerably. Unlike a partnership approach or a multiple-time closed 
event approach, in a participatory approach stakeholders have a role closer in equivalence to a 
researcher role, with responsibility for, and involvement in, all aspects of the review. Our 
examples often described their approach to stakeholder involvement as a “participatory” 
approach. 
 
BOX A:  Types of continuous involvement identified in our examples 
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Table 1: Summary of involvement within the 32 systematic reviews, using the ACTIVE framework  
REVIEW Who was involved? 
How were they 
recruited? 
What happened? Stage and level of involvement 
Approach Method 1 2 3 4 5 6 7 8 9 10
 
11
 
12
 Top 
& 
tail? 
Bayliss 2016 Patients* Closed; exisiting group Continuous 
Direct 
interaction 
   I    I   I      
Boelens 2014 Patients* + other stakeholders Unclear One-time 
No direct 
interaction 
           
Ct
b  
Bond 2015 Patients* + other stakeholders Closed; invitation One-time 
No direct 
interaction 
           R  
Braye 2005 Patients* + other stakeholders Closed; invitation One-time 
Direct 
interaction 
 I         Ct
b   √ 
Bunn 2015 Patients* + other stakeholders 
Closed; 
purposive 
sampling 
One-time Direct interaction 
           R  
Concannon 2014 Patients* + other stakeholders Closed; invitation Continuous 
Direct 
interaction I
 I        I I I √ 
Coon 2016 Patients* + other stakeholders variety Combined 
Direct 
interaction 
  I        Ct
b 
Ct
b R √ 
Edwards 2015 Patients* + other stakeholders Closed; invitation One-time 
Direct 
interaction I
              
Harris 2016 Patients* + other stakeholders Open; fixed Continuous 
Direct 
interaction 
    I   I   I      
Hayden 2015 Other stakeholders only Closed; invitation One-time 
Direct 
interaction I
            R √ 
Higginson 2013 Patients* + other stakeholders Unclear One-time 
Direct 
interaction 
         I     
Hyde 2016 Patients* Closed; exisiting group Continuous 
Direct 
interaction 
 
Ct
b I        Ct
b  
Co
n √ 
Jamal 2015 Patients* Closed; exisiting group One-time 
Direct 
interaction I
              
Liabo 2013 Patients* Open; flexible Continuous Direct interaction Co
n 
Co
n 
Co
n 
Co
n 
Co
n 
Co
n 
Ct
b 
Ct
b I  Ct
b  
Co
n  
Liu 2012 Patients* + other stakeholders Open; flexible Combined 
Direct 
interaction Ct
b         
Ct
b    
Martin 2015 Patients* 
Closed; 
purposive 
sampling 
One-time Direct interaction 
         R    
McConachie 2015 Patients* + other stakeholders Open; flexible One-time 
Direct 
interaction 
 
Ct
b        R    
McCusker 2013 Patients* + other stakeholders Open; flexible One-time 
Direct 
interaction 
           R  
McGinn 2012 Other stakeholders only Closed; invitation One-time 
No direct 
interaction 
           R  
Morgan 2015 Patients* Closed; exisiting group One-time 
Direct 
interaction 
           R  
Oliver 2015 
(“correlational” review)  Patients* 
Closed; exisiting 
group One-time 
Direct 
interaction 
      
Ct
b       
Oliver 2015 (“views” 
review)  Patients* 
Closed; exisiting 
group One-time 
Direct 
interaction 
         
Ct
b    
Oosterkamp 2016 Other stakeholders only Closed; invitation One-time 
No direct 
interaction 
           R  
Pearson 2015 Other stakeholders only Closed; invitation Continuous 
Direct 
interaction Ct
b 
Ct
b        
Ct
b   √ 
Pollock 2014 Patients* + other stakeholders 
Closed; 
purposive 
sampling 
Continuous Direct interaction 
 
Co
n     I   I  Co
n  
Co
n √ 
Rees 2004 Patients* + other stakeholders Closed; invitation Continuous 
Direct 
interaction 
   I      I   Ct
b  
Saan 2015 
(Review 1)  
Other 
stakeholders only Closed; invitation Continuous Unclear I
    I          
Saan 2015 
(Review 2)  
Other 
stakeholders only Closed; invitation One-time 
No direct 
interaction 
   
Ct
b          
Serrano-Anguilar 2009 Patients* Closed; invitation One-time No direct interaction Ct
b             
Smith 2008 Patients* Open; fixed Continuous Direct interaction Ct
b 
Ct
b          
Ct
b √ 
Stewart 2007 Patients* Open; fixed One-time Direct interaction 
           R  
Vale 2012 Patients* Closed; invitation Continuous Direct interaction 
     I      I    
Key:  Patients* - patients, carers and/or their families; Con – Controlling; I – Influencing; Ctb – Contributing; R – 
Receiving.  Blank cells in ‘Stage of involvement’ denote no stakeholder involvement. 
References: see Online supplement 1 
